Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Valeo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10911
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commercializes products in dermatology and other specialty therapeutic areas such as oncology, neurodegenerative diseases, rare and orphan diseases, pain management, including narcotics, and others. Valeo Pharma provides Synacthen indications such as rheumatoid arthritis, psoriatic arthritis, bell’s palsy, acute exacerbations, ulcerative colitis, adjuvant treatment in cases of acute gout, lupus erythematosus, nephrotic syndrome and scleroderma. The company seeks to work in partnership with other pharmaceutical companies and research centers. Valeo Pharma is headquartered in Kirkland, Quebec, Canada.

Valeo Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Valeo Pharma and Besins Healthcare Enter into Agreement 10
Zambon Enters into Agreement with Valeo Pharma 11
Valeo Pharma Enters into Distribution Agreement with Questcor Pharma for Synacthen Depot 12
Asset Transactions 13
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 13
Valeo Pharma Inc – Key Competitors 14
Valeo Pharma Inc – Key Employees 15
Valeo Pharma Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Legal and Regulatory 17
Oct 01, 2018: Manitex Capital announces that its affiliate Valeo Pharma has filed a non-offering preliminary prospectus 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Valeo Pharma and Besins Healthcare Enter into Agreement 10
Zambon Enters into Agreement with Valeo Pharma 11
Valeo Pharma Enters into Distribution Agreement with Questcor Pharma for Synacthen Depot 12
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 13
Valeo Pharma Inc, Key Competitors 14
Valeo Pharma Inc, Key Employees 15

List of Figures
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Giant Eagle, Inc.:企業の戦略・SWOT・財務情報
    Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report Summary Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aurora Health Care Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care. The organization offers its healthcare services to communities throughout eastern Wisconsin and northern Illinois. Its service offerings include primary and s …
  • Strukton Groep NV:企業の戦略・SWOT・財務情報
    Strukton Groep NV - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Confo Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Confo Therapeutics is a drug discovery company that conducts research and development of g protein coupled receptors targeted therapeutics. The company offers CONFO body technology. Its technology uses confobody stabilized functional conformations of g protein coupled receptors. Confo Therap …
  • Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • SOGAZ Insurance Group:企業の戦略・SWOT・財務分析
    SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report Summary SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …
  • Dragon Oil Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Dragon Oil Plc (Dragon Oil), a subsidiary of Emirates National Oil Company Ltd, is an independent oil and gas company that carries out acquisition, exploration, and development of hydrocarbon resources. It focuses on properties in offshore Turkmenistan and exploration assets in Iraq, Algeria …
  • Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報
    Summary Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering p …
  • Elanix Biotechnologies AG (ELN):製薬・医療:M&Aディール及び事業提携情報
    Summary Elanix Biotechnologies AG (Elanix Biotechnologies), formerly Porta Systems AG, is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological and gynecological applications. The company offers GYNrepair cream and SKINrepair cream for skin care …
  • Spire, Inc.:戦略・SWOT・企業財務分析
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Comision Federal de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • University of Massachusetts Medical School:企業のM&A・事業提携・投資動向
    University of Massachusetts Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Massachusetts Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆